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Abstract Gilles de la Tourette syndrome (GTS) is a neu-
rodevelopmental condition characterised by tics and co-
morbid behavioural problems, affecting predominantly
male patients. Tic severity typically fluctuates over time,
with a consistent pattern showing improvement after ado-
lescence in a considerable proportion of patients. Both tics
and behavioural co-morbidities have been shown to have
the potential to affect patients’ health-related quality of life
(HR-QoL) in children and adults with persisting symptoms.
In this study, we present the results of the first investigation
of HR-QoL in patients with Gilles de la Tourette syndrome
at the transition between adolescence and adulthood using
a disease-specific HR-QoL measure, the Gilles de la
Tourette Syndrome-Quality of Life-Children and Adoles-
cents scale. Our results showed that patients with GTS and
more severe co-morbid anxiety symptoms reported lower
HR-QoL across all domains, highlighting the impact of
anxiety on patient’s well-being at a critical stage of
development. Routine screening for anxiety symptoms is
recommended in all patients with GTS seen at transition
clinics from paediatric to adult care, to implement effective
behavioural and pharmacological interventions as
appropriate.
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Introduction
Gilles de la Tourette syndrome (GTS) is a neurodevelop-
mental disorder characterised by multiple motor and pho-
nic tics [1]. The average age at onset of GTS is around
7 years, and a significant reduction of tic severity after
adolescence occurs in about one-third of cases [1]. Co-
morbid behavioural problems are reported by the majority
of patients with GTS, especially attention-deficit and
hyperactivity disorder (ADHD), obsessive–compulsive
disorder (OCD), anxiety and affective disorders [1]. Clin-
ical studies in children and adults with GTS have shown
that both tics and behavioural symptoms can affect
patients’ health-related quality of life (HR-QoL) [2]. To
date, few data are available about the impact of GTS on
HR-QoL at the transition between adolescence and adult-
hood, a crucial age for patients with tic disorders. We,
therefore, set out to investigate HR-QoL and its determi-
nants in a clinical sample of adolescents and young adults
with GTS using a disease-specific HR-QoL measure,
alongside a comprehensive battery of psychometric
instruments [3].
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Methods
Participants
Twenty-two consecutive patients (5 girls) with a diagnosis
of GTS and a mean age of 18 years [age range
15–19 years; standard deviation (SD) 1 year] were recrui-
ted from the Child and Adolescent Neuropsychiatry Out-
patient Unit of the Sapienza University in Rome, Italy.
Each participant/parent provided written informed consent
before enrolment. Eight out of the 22 patients had no co-
morbid psychiatric disorders, 8 were diagnosed with OCD,
4 with ADHD, and 2 with both OCD and ADHD. The
mean age at tic onset was 8 years (SD 3 years). Eighteen
patients were on pharmacotherapy (8 with atypical
antipsychotics, 1 with typical antipsychotics, 2 with
antidepressants, 7 with other medications).
Procedure
Specialist clinicians with extensive experience in tic dis-
orders collected demographic and clinical information and
assessed the severity of tics using the Yale Global Tic
Severity Scale (YGTSS) [4], a clinician-rated instrument
that assesses the number, frequency, intensity, complexity
and interference of motor and phonic tics. YGTSS total tic
severity scores range from 0 (no tics) to 50 (extremely
severe tics). Each participant was subsequently asked to
complete the following psychometric instruments to assess
HR-QoL, premonitory urges, and co-morbid behavioural
symptoms:
– Gilles de la Tourette Syndrome-Quality Of Life-Chil-
dren and Adolescents scale (C&A-GTS-QOL) [5]
The C&A-GTS-QOL is a 27-item, self-report ques-
tionnaire that assesses HR-QoL in young patients with
tic disorders, encompassing 4 areas of HR-QoL:
psychological, physical/activities of daily living, obses-
sive–compulsive, and cognitive domains. Each item is
rated on a 5-point Likert-type scale and higher scores
indicate worse HR-QoL. The instrument includes a
Visual Analogue Scale used to express the extent of
self-satisfaction about life (higher scores indicate
higher satisfaction).
– Premonitory Urge for Tics Scale (PUTS) [6]
The PUTS is a 10-item self-report scale that assesses
premonitory urges to tic. Items from 1 to 9 receive a
score ranging from 1 (never) to 4 (always). Higher
scores indicate the presence of more severe urges.
– State-Trait Anxiety Inventory-form Y (STAI-Y) [7]
The STAI is a 40-item, self-report questionnaire
assessing state (STAI-Y1) and trait anxiety (STAI-
Y2) in subjects older than 12 years. Items are rated on a
4-point Likert-type scale, and higher scores indicate
more severe symptoms.
– Beck Depression Inventory-II (BDI-II) [8]
The BDI-II is a 21-item, self-report questionnaire
assessing depression in subjects older than 13 years.
Items are rated on a 4-point Likert-type scale, and
higher scores indicate more severe symptoms.
Statistical analysis
Participants were divided into subgroups based on the
following grouping variables: (a) gender (male vs female);
(b) tic severity (YGTSS score\10 vs C10); (c) premoni-
tory urge severity (PUTS score\25 vs C25); (d) anxiety
state (STAI-Y1\75 vs C75th centile) and trait (STAI-
Y2\75 vs C75th centile); (e) affective symptoms (BDI-
II\90 vs C90th centile). Differences in GTS-QOL-C&A
scores among subgroups were assessed using the Mann–
Whitney U test. Statistical analyses were performed using
the STATA Statistical Software, Version 8.1.
Results
In our sample, C&A-GTS-QOL total and subscale scores
were lower in patients who reported more severe state and
trait anxiety (Table 1).
Analysis of C&A-GTS-QOL VAS scores confirmed
these findings, as patients with lower levels of anxiety
consistently reported higher overall satisfaction with life.
The negative effects of anxiety symptoms on HR-QoL
were particularly significant in the psychological domain,
whereas the obsessional domain of HR-QoL was also
affected by the presence of more severe urges to tic and
affective symptoms. Patients with at least one co-morbid
psychiatric diagnosis reported higher C&A-GTS-QOL
scores compared to patients with GTS only, although these
differences did not reach statistical significance (p = 0.09).
No significant differences in C&A-GTS-QOL scores were
observed between male and female patients, or between
patients with lower and higher tic severity.
Discussion
We conducted the first study focusing on HR-QoL and its
clinical correlates in patients with GTS at the transition
age between adolescence and adulthood. This is a par-
ticularly delicate age for patients with tic disorders, as the
persistence of symptoms into early adulthood suggests
that the tic disorder might persist throughout life as a
potentially stigmatising condition. Interestingly, in our
1858 Neurol Sci (2016) 37:1857–1860
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clinical sample, neither gender nor tic severity was
associated with decreased HR-QoL, and the impact of
premonitory urges and affective symptoms was limited to
the obsessional domain of HR-QoL. However, we found a
significantly lower report of HR-QoL in patients with
higher levels of state and trait anxiety. These results are
consistent with findings from previous studies using
generic HR-QoL instruments in adult patients with GTS,
which highlighted a pervasive effect of anxiety on HR-
QoL [9] and showed that anxiety symptoms, as well as
affective symptoms, moderate the relationship between tic
severity and functional impairment, such that stronger
relationships are documented in participants with elevated
anxiety or depression [10]. The effects of psychiatric co-
morbidities, especially ADHD and OCD, on the HR-QoL
of patients within this age group deserve further investi-
gation, based on our preliminary findings [11]. Limita-
tions of the present study include the relatively small
sample size (especially with regard to the subgroup of
patients with GTS only), referral bias, use of self-report
measures and retrospective design. Our findings highlight
the crucial role that anxiety symptoms play in influencing
the psychological well-being of patients with GTS from
adolescence to early adulthood. Routine screening for
anxiety symptoms is recommended in all patients with
GTS seen at transition clinics from paediatric to adult
care, to implement effective behavioural and pharmaco-
logical interventions as appropriate.
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